Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
RUNX1 mutations contribute to the progression of MDS due to disruption of antitumor cellular defense: a study on patients with lower-risk MDS.
Kaisrlikova M, Vesela J, Kundrat D, Votavova H, Dostalova Merkerova M, Krejcik Z, Divoky V, Jedlicka M, Fric J, Klema J, Mikulenkova D, Stastna Markova M, Lauermannova M, Mertova J, Soukupova Maaloufova J, Jonasova A, Cermak J, Belickova M. Kaisrlikova M, et al. Among authors: jonasova a. Leukemia. 2022 Jul;36(7):1898-1906. doi: 10.1038/s41375-022-01584-3. Epub 2022 May 3. Leukemia. 2022. PMID: 35505182 Free PMC article.
Defective cytotoxicity of T lymphocytes in myelodysplastic syndrome.
Cukrová V, Neuwirtová R, Dolezalová L, Belicková M, Bartůnková J, Jonásová A, Cermák J, Homolková H, Malíková I. Cukrová V, et al. Among authors: jonasova a. Exp Hematol. 2009 Mar;37(3):386-94. doi: 10.1016/j.exphem.2008.11.001. Epub 2009 Jan 10. Exp Hematol. 2009. PMID: 19136196 Free article.
Nature of frequent deletions in CEBPA.
Fuchs O, Kostecka A, Provaznikova D, Krasna B, Brezinova J, Filkukova J, Kotlin R, Kouba M, Kobylka P, Neuwirtova R, Jonasova A, Caniga M, Schwarz J, Markova J, Maaloufova J, Sponerova D, Novakova L, Cermak J. Fuchs O, et al. Among authors: jonasova a. Blood Cells Mol Dis. 2009 Nov-Dec;43(3):260-3. doi: 10.1016/j.bcmd.2009.07.001. Epub 2009 Aug 3. Blood Cells Mol Dis. 2009. PMID: 19651529
Deletion of the long arm but not the 5q31 region of chromosome 5 in myeloid malignancies.
Brezinova J, Zemanova Z, Bystricka D, Sarova I, Lizcova L, Malinova E, Izakova S, Sajdova J, Sponerova D, Jonasova A, Cermak J, Michalova K. Brezinova J, et al. Among authors: jonasova a. Leuk Res. 2012 Mar;36(3):e43-5. doi: 10.1016/j.leukres.2011.11.007. Epub 2011 Dec 6. Leuk Res. 2012. PMID: 22153775 No abstract available.
5-azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity.
Curik N, Burda P, Vargova K, Pospisil V, Belickova M, Vlckova P, Savvulidi F, Necas E, Hajkova H, Haskovec C, Cermak J, Krivjanska M, Trneny M, Laslo P, Jonasova A, Stopka T. Curik N, et al. Among authors: jonasova a. Leukemia. 2012 Aug;26(8):1804-11. doi: 10.1038/leu.2012.47. Epub 2012 Feb 20. Leukemia. 2012. PMID: 22343522
Recurrent chromosomal breakpoints in patients with myelodysplastic syndromes and complex karyotype versus fragile sites.
Bystricka D, Sarova I, Zemanova Z, Brezinova J, Lizcova L, Izakova S, Dostalova Merkerova M, Krejcik Z, Siskova M, Jonasova A, Neuwirtova R, Cerna O, Cermak J, Michalova K. Bystricka D, et al. Among authors: jonasova a. Leuk Res. 2012 Jun;36(6):e125-7. doi: 10.1016/j.leukres.2012.02.006. Epub 2012 Mar 3. Leuk Res. 2012. PMID: 22391389 No abstract available.
Thrombocytopenia at diagnosis as an important negative prognostic marker in isolated 5q- MDS (IPSS low and intermediate-1).
Jonasova A, Cermak J, Vondrakova J, Siskova M, Hochova I, Kadlckova E, Cerna O, Sykora M, Vozobulova V, Seifertova N, Michalova K, Zemanova Z, Brezinova J, Belohlavkova P, Kostecka A, Neuwirtova R. Jonasova A, et al. Leuk Res. 2012 Dec;36(12):e222-4. doi: 10.1016/j.leukres.2012.08.002. Epub 2012 Sep 3. Leuk Res. 2012. PMID: 22954608 No abstract available.
75 results